PF-08046054 by Pfizer for Solid Tumor: Likelihood of Approval

While use of PubMed’s voluntary field for conflict of interest (COI) statements in abstracts has increased, it continues to be underutilized by most scientific journals,

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it